David M. Jacobs PharmD, PhD

David Jacobs

David M. Jacobs
PharmD, PhD

Contact Information
316 Pharmacy Building
Buffalo, NY
Phone: (716)829-2134
dmjacobs@buffalo.edu



Professional Summary:

The focus and application of my research program is centered on the intersection of pharmaceutical health services, pharmacoepidemiology, and implementation science. My research approach emphasizes multi-disciplinary and collaborative research strategies encompassing interventional, observational, and mixed methods across a variety of therapeutic areas. Specifically, my current research has three main areas of focus:

1) use of large data sets, data mining techniques, and comparative effectiveness research to predict and evaluate outcomes of acute and chronic medications,

2) implementation and evaluation of pharmacist care services to improve patient safety and care quality,

3) optimizing chronic disease management and treatment adherence through cost-effective approaches.

Member of Team Alice, an interprofessional initiative to protect older adults from medication related harm.

Education and Training:

  • PhD, Epidemiology, University at Buffalo School of Public Health and Health Professions (2018)
  • Fellowship, Clinical Pharmacokinetics Laboratory (2014)
  • PGY-2 Infectious Diseases Residency, Universtiy of Houston College of Pharmacy (2013)
  • PGY-1 Pharmacy Practice Residency, University of Toledo Medical Center (2012)
  • PharmD, Pharmacy, University at Buffalo School of Pharmacy and Pharmaceutical Sciences (2011)
  • BS, Chemistry, Binghamton University (2007)

Employment:

  • Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2018-present)
  • Clinical Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2014–2018)

Awards and Honors:

  • Saxon Graham Award for Academic Excellence in Epidemiology, School of Public Health and Health Professions, University at Buffalo (2019)
  • Faculty Research Award, Department of Pharmacy Practice, UB School of Pharmacy and Pharmaceutical Sciences (2019)
  • Presentation Merit Award Semifinalist, Annual Meeting of the American Pharmacists Association (2019)
  • Best Research Poster Award Finalist, 24th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2019)
  • Holger Schunemann Award for Graduate Student Research, Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo (2018)
  • Delta Omega Honorary Society in Public Health, University at Buffalo (2018)
  • Best Poster Finalist, 22nd Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
  • Infectious Diseases Society of America Travel Grant (2016)
  • Who's Who Among Students in American Universities and Colleges (2015)
  • International Society of Pharmacoeconomics and Outcomes Research Travel Grant (2015)
  • Infectious Diseases Society of America Fellow Travel Grant (2014)
  • Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID) Resident Travel Grant (2013)
  • Shining Star Award, University of Toledo (2011)
  • Mylan Pharmaceutical Inc., Excellence in Pharmacy Award (2011)
  • American Assoication of Colleges of Pharmacy - Wal Mart Scholarship (2010)

Grants and Sponsored Research:

  • March 2023–February 2024
    A Pilot Pharmacist-to-pharmacist Hand-off Intervention During Transitions of Care
    American Association of Colleges of Pharmacy
    Role: Co-Investigator
    $7,500
  • August 2020–July 2021
    Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging
    US Deprescribing Research Network
    Role: Co-Investigator
    $60,000
  • July 2020–June 2021
    Comparison of triple therapy with apixaban vs. rivaroxabn
    American College of Clinical Pharmacy Cardiology PRN
    Role: Co-Investigator
  • July 2019–June 2021
    Implementation Research to Improve Medication Management in COPD
    NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research
    Role: Principal Investigator
  • July 2019–June 2021
    Impact of an integrated pharmacist and primary care collaborative transitions of care program on clinical and economic outcomes among high risk patients
    ASHP Foundation
    Role: Principal Investigator
    $77,618
  • May 2019–April 2021
    Development and implementation of a chronic obstructive pulmonary disease care transition intervention integrating pharmacists onto the care team.
    NIH/National Heart, Lung, and Blood Institute (1K12HL138052-01)
    Role: Principal Investigator
  • May 2019–April 2021
    Community-Based Participatory Research for Reducing Medication Harm among Retirees
    Retirement Research Foundation
    Role: Co-Investigator
    $200,000
  • January 2020–January 2021
    Impact and feasibility of establishing a community health worker program within community pharmacy settings
    Community Pharmacy Foundation
    Role: Principal Investigator
  • August 2019–July 2020
    The Deprescribing Network of Western New York for Successful Aging
    UB Seeds for Innovation in Successful Aging
    Role: Co-Investigator
    $30,000
  • July 2018–June 2020
    Pain medication prescription following treatment for alcohol use disorder
    National Institute on Alcoholism and Alcohol Abuse
    Role: Co-Investigator
    $386,013
  • September 2017–September 2019
    Optimizing Pain Management and Opioid Safety: A Community Pharmacy Intervention to Prevent Opioid Adverse Drug Events
    Centers for Medicare and Medicaid Services
    Role: Co-Investigator
  • July 2017–June 2019
    Clinical Epidemiology in Chronic Obstructive Pulmonary Disease
    NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research
    Role: Principal Investigator
  • February 2018–April 2019
    A Pilot Study to Evaluate Objective Assessment Tools to Improve Medication Management in Chronic Obstructive Pulmonary Disease
    Buffalo Translational Consortium Mentored Career Development Award
    Role: Principal Investigator
  • February 2017–June 2018
    Proton pump Inhibitors and the Risk of Acute Kidney Disease and Chronic Kidney Disease in a Medicaid Population
    University at Buffalo School of Pharmacy and Pharmaceutical Sciences Seed Grant
    Role: Principal Investigator
  • July 2015–June 2017
    Multi-Center Characterization of the Treatment of Candiduria
    Astellas Pharmaceuticals Investigator Initiated Research
    Role: Principal Investigator
  • January 2016–December 2016
    Development of a Clinical Risk Score to Identify 30-day Rehospitalization among Patients on Outpatient Intravenous Antibiotic Therapy
    Research for Health in Erie County, Inc.
    Role: Principal Investigator
See all (6 more)

Journal Articles:

See all (42 more)

Books and Book Chapters:

  • Cappelletty DM, Jacobs DM, Klochan SA. "Community-Acquired Pneumonia". 2014.

Abstracts:


Professional Memberships:

  • Loan Repayment Program Ambassador, Division of Loan Repayment, National Institutes of Health (2018–present)
  • International Society of Pharmacoeconomics and Outcomes Research (2016–present)
  • Society of Infectious Disease Pharmacists (2012–present)
  • American College of Clinical Pharmacy (2011–present)
  • American Association of Colleges of Pharmacy (2010–present)

Presentations:

  • "A systematic review on the impact of antifungal stewardship interventions in the United States" Annual meeting of the American College of Clinical Pharmacy (2018)
  • "Adjuvant β-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does β-lactam class matter." Annual Meeting of the Infectious Diseases Society of America (2018)
  • "Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study" Annual meeting of the American College of Clinical Pharmacy (2018)
  • "Characterization of candiduria treatment: a multi-institutional study." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (2017)
  • "Risk factors for healthcare utilization among patients discharged on outpatient parenteral antimicrobial therapy." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (ASM Microbe), (2017)
  • "Changing Epidemiology of Pneumococcal Meningitis in the United States, 2008-2013." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
  • "The utility of procalcitonin to support clinical decision making in critically ill pediatric patients." 54th Annual Meeting of the Infectious Diseases Society of America (2016)
  • "Incidence and outcomes of S. aureus pneumonia among hospitalized patients in the United States, 2009 – 2012." International Society of Pharmacoeconomics and Outcomes Research (2016)
  • "Early beta-lactam therapy combined with standard therapy for methicillin-resistant S. aureus bloodstream infections compared to standard therapy alone: a multicenter, restrospective, propensity-matched analysis." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
  • "Shifts in incidence and mortality of ESKAPE septicemia among US hospitalized patients from 2008-2012" 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (2015)
  • "Triple antibiotic combinations for the treatment of carbapenemase-producing Enterobacteriaceae (CPE): an outcomes based systematic review." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
  • "Current attitudes and perceptions of dual PharmD/MBA degree program students: a qualitative analysis." Annual meeting of the American Association of Colleges of Pharmacy (2015)
  • "Impact of a master of business administration (MBA) degree on the career of a pharmacists." Annual meeting of the American Association of Colleges of Pharmacy (2015)
  • "Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with MRSA skin and soft tissue infections." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, (2015)
  • "Evaluation of bleeding outcomes linked to new oral anticoagulants: a review of the FDA adverse event reporting system." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2015)
  • "Analysis of an enhanced medication letter initiative within a Medicaid retrospective drug utilization program" Annual meeting of the American Pharmacists Association (2015)
  • "Effectiveness of a mailed letter intervention to address potentially inappropriate psychiatric medication use with a Medicaid fee-for service population" Annual meeting of the American Pharmacists Association (2015)
  • "Antibiotic polytherapy against multidrug-resistant, KPC-2 producing Enterobacter infections: case series and systematic review" Annual meeting of the American College of Clinical Pharmacy (2014)
  • "Comparison of weight and metabolic profiles in patients treated with an oral mimetic of the Roux-en-Y gastric bypass effect" Annual meeting of the American Gastroenterological Association at Digestive Disease Week (2014)
  • "Host factors for Candida colonization in critically ill patients" 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (2013)
See all (10 more)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

316 Pharmacy Building
Buffalo, NY
Phone: (716)829-2134
dmjacobs@buffalo.edu